Middle East & Africa Lipid Market Size & Outlook
Middle East & Africa lipid market, 2018-2030 (US$M)
Related Markets
MEA lipid market highlights
- The MEA lipid market generated a revenue of USD 1,136.3 million in 2022.
- The market is expected to grow at a CAGR of 6.7% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 1,136.3 million |
| Market revenue in 2030 | USD 1,902.1 million |
| Growth rate | 6.7% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, MEA region accounted for 12.1% of the global lipid market in 2022.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,340.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.45% in 2022. Horizon Databook has segmented the Middle East & Africa lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceuticals industry in the Middle East is witnessing a boost with increase in aging population and higher spending on health. With the increase in health awareness of consumers post COVID-19 outbreak, the pharmaceutical industry has seen a higher consumer spending on drugs.
Some of these drugs are made of lipids that are used in COVID-19 vaccines. The increasing malnutrition cases in Africa are also expected to positively impact the nutritional & supplements demand, which, in turn, will impact the lipid market over the forecast period.
According to National Library of Medicine, around 10% children under the age of five from middle and low income countries are suffer from malnutrition, mostly from South Asia and Africa. This is expected to boost the demand for nutrition and supplements, which, in turn, will positively impact the lipid market demand.
Reasons to subscribe to Middle East & Africa lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa lipid market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA lipid market size, by country, 2018-2030 (US$M)
Middle East & Africa Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
